Dainippon Sumitomo Reports Significant Revenue Increase
This article was originally published in PharmAsia News
Executive Summary
Dainippon Sumitomo Pharma saw an 11.9% increase in domestic pharmaceutical sales for ARB Avapro, Lonasen for schizophrenia and Prorenal to improve peripheral circulation.